DOI: https://doi.org/10.15674/0030-598720181117-124

Hyaluronic acid drugs in the treatment of joint pathology (literature review)

Oleg Vyrva, Nataliya Ashukina

Abstract


On the base of literature review the possibility of hyaluronic acid application in the treatment of patients with arthritis and diseases of joint adjacent tissues was assessed. hyaluronic acid is important component of joint tissues, provides its normal function. At arthritis changes appear normal concentration of hyaluronic acid and its molecular weight decreases, it can lead to the violation of structural and biomechanical joint properties. Increasing of the level of hyaluronic acid in the joint due to intraarticular injections can help to restore viscosity properties of synovial fluid, provides chondroprotective, anti-inflammatory and pain relief actions. The most studied mechanism of hyaluronic acid is its ability to connect with CD44, due to this interleikin 1β, 6 and 8, prostaglandin E2, metalloproteinase expression are suppressed. Hyaluronic acid promotes the synthesis of chondral matrix (proteoglycans and collagen), decreases the frequency of chondrocytes apoptosis. Ability of hyaluronic acid to activate the migration of slightly differentiated cells and proliferation of fibroblasts could use it for the treatment of joint pathology. The results of the most of the studies, systematic reviews and meta-analysis tell about positive clinical appliance of hyaluronic acid drugs in the treatment of arthritis of the I–III stages. But the efficacy of such medicines depends on its origin, molecular weight, elasticity and duration of treatment. New direction of intraarticular therapy is combination of hyaluronic acid with chondroitin sulfate, which provide symptomatic and chondromodification action. For the discovery of the full mechanism of influence further studies must be performed. Drugs Sertobec can be medical drugs for the treatment of patients with arthritis and diseases of joint adjacent tissues.


Keywords


arthritis; treatment, injection therapy; hyaluronic acid; mechanism of action; Sertobec

References


Zhang, Y., & Jordan, J. M. (2010). Epidemiology of Osteoarthritis. Clinics in Geriatric Medicine, 26(3), 355-369. doi:10.1016/j.cger.2010.03.001

Kovalenko, V. N., Bortkevych, O. P., & Boichuk, N. S. (2015). Primeneniye preparatov gialuronovoy kisloty dlya lecheniya pri osteoartroze [The use of hyaluronic acid for the treatment of osteoarthritis]. Ukrayins’kyy revmatolohichnyy zhurnal, 1 (59), 51–54. (in Russian)

Lespasio, M. J., Piuzzi, N. S., Husni, M. E., Muschler, G. F., Guarino, A., & Mont, M. A. (2017). Knee Osteoarthritis: A Primer. The Permanente Journal, 21, 16–183. http://doi.org/10.7812/TPP/16-183

Lespasio, M. J., Sultan, A. A., Piuzzi, N. S., Khlopas, A., Husni, M. E., Muschler, G. F., & Mont, M. A. (2018). Hip Osteoarthritis: A Primer. The Permanente Journal,22, 17–084. http://doi.org/10.7812/TPP/17-084

Roos, E. M., & Arden, N. K. (2015). Strategies for the prevention of knee osteoarthritis. Nature Reviews Rheumatology, 12(2), 92-101. doi:10.1038/nrrheum.2015.135

Weinstein, A. M., Rome, B. N., Reichmann, W. M., Collins, J. E., Burbine, S. A., Thornhill, T. S., … Losina, E. (2013). Estimating the Burden of Total Knee Replacement in the United States. The Journal of Bone and Joint Surgery. American Volume, 95(5), 385–392. http://doi.org/10.2106/JBJS.L.00206

Kiadaliri, A. A., Lohmander, L. S., Moradi-Lakeh, M., Petersson, I. F., & Englund, M. (2017). High and rising burden of hip and knee osteoarthritis in the Nordic region, 1990–2015. Acta Orthopaedica, 1-7. doi:10.1080/17453674.2017.1404791

Korzh, M., Gaiko, G., Filipenko, V., Gerasimenko, S., & Tankut, V. (2014). Status and problematic issues of joint replacement in Ukraine (an enforcement of the XVI Congress of orthopaedics and traumatologists of Ukraine). Orthopaedics, Traumatology and Prosthetics, 1, 81-86. doi:http://dx.doi.org/10.15674/0030-59872014181-86 (in Ukrainian)

Pavlova, V. N., Pavlov, G. G., & Shostak, N. A. (Eds.) (2011). Sustav: morfologiya, klinika, diagnostika, lecheniye [Joint: morphology, clinic, diagnosis, treatment]. Moscow: ООО “Izd-vo “Meditsinskoye «Meditsinskoye informatsionnoye agentstvo». (in Russian)

Korzh, N. A., Dedukh, N. V., & Zupanats, I. A. (Eds.) (2007). Osteoartroz: konservativnaya terapiya [Osteoarthritis: conservative therapy]. Kharkov: Zolotie stranitsi. (in Russian)

Vyrva, O. E. (2000). Artificial synovial fluid in the treatment of pathology of the knee joint. Orthopaedics, Traumatology and Prosthetics, 2, 146–150. (in Russian)

Fedorishchev, I. A. (2011). Hyaluronic acid. Book 1. TulGU. (in Russian)

Sigaeva, N. N., Kolesov, S. V., Nazarov, P. V., & Vildaniva, R. R. (2012). Khimicheskaya modifikatsiya gialuronovoy kisloty i yeye primeneniye v meditsine [Chemical modification of hyaluronic acid and its use in medicine]. Vestnik Bashkirskogo universiteta, 17 (3), 1220-1241. (in Russian)

Goldberg, V., & Buckwalter, J. (2005). Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis and Cartilage, 13(3), 216-224. doi:10.1016/j.joca.2004.11.010

Goldberg, V. (2010). Intra-articular hyaluronans: the treatment of knee pain in osteoarthritis. Journal of Pain Research, 51. doi:10.2147/jpr.s4733

Henrotin, Y., Hauzeur, J., Bruel, P., & Appelboom, T. (2012). Intra-articular use of a medical device composed of hyaluronic acid and chondroitin sulfate (Structovial CS): effects on clinical, ultrasonographic and biological parameters. BMC Research Notes, 5(1), 407. doi:10.1186/1756-0500-5-407

Ando, A., Hagiwara, Y., Chimoto, E., Hatori, K., Onoda, Y., & Itoi, E. (2008). Intra-articular Injection of Hyaluronan Diminishes Loss of Chondrocytes in a Rat Immobilized-Knee Model. The Tohoku Journal of Experimental Medicine, 215(4), 321-331. doi:10.1620/tjem.215.321

Brun, P., Zavan, B., Vindigni, V., Schiavinato, A., Pozzuoli, A., Iacobellis, C., & Abatangelo, G. (2012). In vitroresponse of osteoarthritic chondrocytes and fibroblast-like synoviocytes to a 500-730 kDa hyaluronan amide derivative. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 100B(8), 2073-2081. doi:10.1002/jbm.b.32771

Julovi, S. M., Yasuda, T., Shimizu, M., Hiramitsu, T., & Nakamura, T. (2004). Inhibition of interleukin-1?-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis & Rheumatism, 50(2), 516-525. doi:10.1002/art.20004

Mongkhon, J., Thach, M., Shi, Q., Fernandes, J. C., Fahmi, H., & Benderdour, M. (2014). Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes. Inflammation Research, 63(8), 691-701. doi:10.1007/s00011-014-0742-4

Peng, H., Zhou, J., Liu, S., Hu, Q., Ming, J., & Qiu, B. (2010). Hyaluronic acid inhibits nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes in vitro. Inflammation Research, 59(7), 519-530. doi:10.1007/s00011-010-0156-x

Altman, R., Manjoo, A., Fierlinger, A., Niazi, F., & Nicholls, M. (2015). The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskeletal Disorders, 16(1). doi:10.1186/s12891-015-0775-z

De la Peña, E., Sala, S., Rovira, J. C., Schmidt, R. F., & Belmonte, C. (2002). Elastoviscous substances with analgesic effects on joint pain reduce stretch-activated ion channel activity in vitro. Pain, 99(3), 501-508. doi:10.1016/s0304-3959(02)00260-9

Forsey, R., Fisher, J., Thompson, J., Stone, M., Bell, C., & Ingham, E. (2006). The effect of hyaluronic acid and phospholipid based lubricants on friction within a human cartilage damage model. Biomaterials, 27(26), 4581-4590. doi:10.1016/j.biomaterials.2006.04.018

Lu, H., Sheu, M., Lin, Y., Lan, J., Chin, Y., Hsieh, M., … Chen, C. (2013). Injectable hyaluronic-acid-doxycycline hydrogel therapy in experimental rabbit osteoarthritis. BMC Veterinary Research, 9(1), 68. doi:10.1186/1746-6148-9-68

Prasadam, I., Crawford, R., & Xiao, Y. (2012). Aggravation of ADAMTS and Matrix Metalloproteinase Production and Role of ERK1/2 Pathway in the Interaction of Osteoarthritic Subchondral Bone Osteoblasts and Articular Cartilage Chondrocytes – Possible Pathogenic Role in Osteoarthritis. The Journal of Rheumatology, 39(3), 621-634. doi:10.3899/jrheum.110777

Hiraoka, N., Takahashi, K., Arai, Y., Honjo, K., Nakagawa, S., Tsuchida, S., … Kubo, T. (2009). 164 hyaluronan and intermittent hydrostatic pressure synergistically suppressed MMP-13 AND il-6 expressions in osteoblasts from OA subchondral bone. Osteoarthritis and Cartilage, 17, S97. doi:10.1016/s1063-4584(09)60186-2

Ding, M., Christian Danielsen, C., & Hvid, I. (2005). Effects of hyaluronan on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Bone, 36(3), 489-501. doi:10.1016/j.bone.2004.12.010

Piuzzi, N. S., Midura, R. J., Muschler, G. F., & Hascall, V. C. (2018). Intra-articular hyaluronan injections for the treatment of osteoarthritis: perspective for the mechanism of action. Therapeutic Advances in Musculoskeletal Disease, 10(2), 55-57. doi:10.1177/1759720x17752038

Bagga, H., Burkhardt, D., Sambrook, P., & March, L. (2006). Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. Journal of Rheumatology, 33, 946-950.

Migliore, A., Giovannangeli, F., Granata, M., & Laganà, B. (2010). Hylan G-F 20: Review of its Safety and Efficacy in the Management of Joint Pain in Osteoarthritis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 3, 117954411000300. doi:10.1177/117954411000300001

Raman, R., Dutta, A., Day, N., Sharma, H., Shaw, C., & Johnson, G. (2008). Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee — A prospective randomized clinical trial. The Knee, 15(4), 318-324. doi:10.1016/j.knee.2008.02.012

Gigis, I., Fotiadis, E., Nenopoulos, A., Tsitas, K., & Hatzokos, I. (2016). Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Hippokratia, 20(1), 26–31.

Miltner, O., Schneider, U., Siebert, C., Niedhart, C., & Niethard, F. (2002). Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis—a prospective clinical trial. Osteoarthritis and Cartilage, 10(9), 680-686. doi:10.1053/joca.2002.0815

Vaskova, N. V., & Lesniak, O. M. (2014). Preparaty gialuronovoy kisloty v lechenii osteoartroza kolennykh sustavov [Hyaluronic acid in the treatment of knee osteoarthritis]. Rossiyskiy semeynyy vrach, 18(3), 29-34. (in Russian).

Dougados, M. (2000). Sodium hyaluronate therapy in osteoarthritis: Arguments for a potential beneficial structural effect.Seminars in Arthritis and Rheumatism, 30(2), 19-25. doi:10.1053/sarh.2000.0246

Bannuru, R. R., Schmid, C. H., Kent, D. M., Vaysbrot, E. E., Wong, J. B., & McAlindon, T. E. (2015). Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Annals of Internal Medicine, 162, 46–54. doi: 10.7326/M14-1231

Miller, L., Strand, V., McIntyre, L., Beach, W., & Block, J. (2015). Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials. Journal of Pain Research, 217. doi:10.2147/jpr.s83076

Bannuru, R. R., Natov, N. S., Dasi, U. R., Schmid, C. H., & McAlindon, T. E. (2011). Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis. Osteoarthritis Cartilage, 19 (6), 611–619. doi: 10.1016/j.joca.2010.09.014

Bannuru, R. R., Natov, N. S., Obadan, I. E., Price, L. L., Schmid, C. H., & McAlindon, T. E. (2009). Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Arthritis & Rheumatism, 61(12), 1704-1711. doi:10.1002/art.24925

Campbell, K. A., Erickson, B. J., Saltzman, B. M., Mascarenhas, R., Bach, B. R., Cole, B. J., & Verma, N. N. (2015). Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee: A Systematic Review of Overlapping Meta-analyses. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 31(10), 2036-2045.e14. doi:10.1016/j.arthro.2015.03.030

Rutjes, A. W., Juni, P., da Costa, B. R., Trelle, S., Nüesch, E., & Reichenbach, S. (2012). Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Annals of Internal Medicine, 157 (3), 180–191.

Altman, R. D., Bedi, A., Karlsson, J., Sancheti, P., & Schemitsch, E. (2016). Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee. The American Journal of Sports Medicine, 44 (8), 2158-2165. doi: 10.1177/0363546515609599

Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system. Seminars in Arthritis and Rheumatism, 31(1), 58-68. doi:10.1053/sarh.2000.24874

McAlindon, T. E., LaValley, M. P., Gulin, J. P., & Felson, D. T. (2000). Glucosamine and Chondroitin for Treatment of Osteoarthritis. JAMA, 283(11), 1469. doi:10.1001/jama.283.11.1469

Anikin, S. G., & Alekseeva, L. I. (2012). Khondroitina sul'fat: mekhanizmy deystviya, effektivnost' i bezopasnost' pri terapii osteoartroza [Chondroitin sulfate: mechanisms of action, efficacy and safety in the treatment of osteoarthritis]. Sovremennaya revmatologiya, 3, 78-82. (in Russian)

Shuba, N. M., Voronova T. D., & Krylova, A. S. (2013). Vybor strukturno-modifitsiruyushchikh i protivovospalitel'nykh preparatov u patsiyentov s osteoartrozom [The choice of structural-modifying and anti-inflammatory drugs in patients with osteoarthritis]. Ukrayinskyy revmatolohichnyy zhurnal, 2 (52), 67-73. (in Russian)

Hochberg, M. (2010). Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis and Cartilage, 18, S28-S31. doi:10.1016/j.joca.2010.02.016

Tosun, H. B., Gürger, M., Gümüştaş, S. A., Uludag, A., Üçer, Ö., Serbest, S., & Çelik, S. (2017). The effect of sodium hyaluronate–chondroitin sulfate combined solution on cartilage formation in osteochondral defects of the rabbit knee: an experimental study. Therapeutics and Clinical Risk Management, 13, 523-532. doi:10.2147/tcrm.s133635

Rivera, F., Bertignone, L., Grandi, G., Camisassa, R., Comaschi, G., Trentini, D., … Fortina, G. (2016). Effectiveness of intra-articular injections of sodium hyaluronate-chondroitin sulfate in knee osteoarthritis: a multicenter prospective study. Journal of Orthopaedics and Traumatology, 17(1), 27-33. doi:10.1007/s10195-015-0388-1

Udovika, M. I., Zhiliaev. E. V., & Anoshenkova, O. N. (2017). Effektivnost lokalnykh inyektsiy gialuronata natriya v terapii zabolevaniy myagkikh okolosustavnykh tkaney [Effectiveness of local injections of sodium hyaluronate in the therapy of diseases of soft periarticular tissues]. Poliklinila, 2, 98–104. (in Russian)

Gorelick, L., Gorelick, A. R., Saab, A., Ram, E., & Robinson, D. (2015). Lateral epicondylitis injection therapy: a safety and efficacy analysis of hyaluronate versus corticosteroid injections. Advanced Techniques in Biology & Medicine 3:130. doi:10.4172/2379- 1764.1000130

Khan, I. U., Awan, A. S., Khan, A. S., Marwat, I., & Meraj, M. (2018). Efficacy of a single-injection sodium hyaluronate treatment in lateral epicondylitis. Journal of Ayub Medical College Abbottabad Pakistan, 30 (1), 85-89.

Noble, P. W., Liang, J., & Jiang, D. (2011). Hyaluronan as an immune regulator in human diseases. Physiological Reviews, 91(1), 221–264. http://doi.org/10.1152/physrev.00052.2009




Copyright (c) 2018 Oleg Vyrva, Nataliya Ashukina

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.